Ignite Creation Date:
2025-12-24 @ 11:38 PM
Ignite Modification Date:
2026-01-02 @ 10:59 PM
Study NCT ID:
NCT03992456
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-05-21
First Post:
2019-06-18
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Panitumumab, Regorafenib, or TAS-102, in Treating Patients With Metastatic and/or Unresectable RAS Wild-Type Colorectal Cancer
Sponsor:
Organization: